Cite Filings / EW / 0001099800-26-000015
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
DEF 14A

Proxy Statement

Edwards Lifesciences Corp · Filed 2026-03-26 · Acc 0001099800-26-000015

Documents 1

  • DEF 14A Proxy Statement , ew-20260326.htm

Around this filing

  • 2026-04-02 4 CVP,Strategy/Corp Development sold 22,680 shares at an average $80.16 ($1,818,055)
  • 2026-03-26 DEFA14A Proxy Materials
  • 2026-03-26 ARS Annual Report to Security Holders
  • 2026-03-26 DEFA14A Proxy Materials
  • 2026-03-26 DEF 14A Proxy Statement
  • 2026-03-26 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2025-03-26 DEF 14A Proxy Statement

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading ew-20260326.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…